Apollomics APLM
NASDAQ APLM
$22.05 +0.95 (+4.56%)
As of: Oct 19, 2026 · 12:55 PM EDT

Apollomics (APLM) Common Equity (2020 - 2025)

Updated

Apollomics (APLM) recorded Common Equity of -$275,000 in Q4 2025, compared with $2.87 million a year earlier.

Analysis

Apollomics (APLM) Common Equity (2020 - 2025) Analysis & Trends

Starting with Q4 2021, Apollomics' Common Equity history includes 9 quarters.

  • Across earlier years, Common Equity came in at $2.87 million in FY2024 (-93.0%), $41.23 million in FY2023, -$448.12 million in FY2022 and -$212.86 million in FY2021.
  • Quarterly Common Equity has ranged from -$448.12 million in Q4 2022 to $55.7 million in Q2 2023 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,131.65 Bn 1,100.24 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 615.89 Bn 534.41 Bn 17.26 Bn 84.97 Bn
3 AbbVie 505.03 Bn 478.14 Bn 12.70 Bn -5.94 Bn
4 Merck 368.78 Bn 323.16 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 298.66 Bn 262.65 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 262.09 Bn 235.78 Bn 12.86 Bn 50.37 Bn
7 Amgen 236.57 Bn 191.97 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 191.05 Bn 165.25 Bn 6.22 Bn 11.83 Bn
9 Pfizer 170.60 Bn 117.25 Bn 10.94 Bn 85.49 Bn
10 Apollomics 44.32 Mn 3.22 Mn - -3.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.20 Mn
Jun 30, 2025 -4.40 Mn
Dec 31, 2024 4.86 Mn
Jun 30, 2024 20.81 Mn
Dec 31, 2023 41.23 Mn
Jun 30, 2023 55.70 Mn
Dec 31, 2022 -448.12 Mn
Jun 30, 2022 -212.49 Mn
Dec 31, 2021 -212.86 Mn
Dec 31, 2020 -127.93 Mn
API Access

Apollomics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=APLM&period=max&api_key=YOUR_API_KEY